Other Species / Isoforms
  PINX1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R7-m1
_MSMLAErRRKQkWA
0 1
PINX1 (human) _MSMLAErRRKQkWA R7-m1
PINX1 (mouse) _MSMLAERRRKQKWT R7
PINX1 (rat) _MSMLAERRRKQKWA R7
K12-ub
AErRRKQkWAVDPQN
0 1
PINX1 (human) AErRRKQkWAVDPQN K12-ub
PINX1 (mouse) AERRRKQKWTVDPRN K12
PINX1 (rat) AERRRKQKWAVDPRN K12
S110-p
SDKKEKKsFSLEEKs
Upstream
Downstream
1 2
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • GW_843682X
  • nocodazole
PINX1 (human) SDKKEKKsFSLEEKs S110-p
PINX1 (mouse) SDKKEKKSFSLEEKS S110
PINX1 (rat) SDNKEKKSFSLEEKS S110
S117-p
sFSLEEKsKISKNRV
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • GW_843682X
  • nocodazole
PINX1 (human) sFSLEEKsKISKNRV S117-p
PINX1 (mouse) SFSLEEKSKISKNRV S117
PINX1 (rat) SFSLEEKSKISKNRV S117
Y126-p
ISKNRVHyMKFTKGK
0 3
PINX1 (human) ISKNRVHyMKFTKGK Y126-p
PINX1 (mouse) ISKNRVHYMKFTKGK Y126
PINX1 (rat) ISKNRVHYMKFTKGK Y126
T141-p
DLSSRSKtDLDCIFG
Upstream
Downstream
1 2
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • GW_843682X
  • nocodazole
PINX1 (human) DLSSRSKtDLDCIFG T141-p
PINX1 (mouse) DLSSRSETDLDCIFG T141
PINX1 (rat) DLSSRSETDLDCIFG T141
S161-p
KTPEGDAsPstPEEN
0 6
PINX1 (human) KTPEGDAsPstPEEN S161-p
PINX1 (mouse) ADEVNTSLTTTTTTT L172
PINX1 (rat) ADEADTSLTTTTTTT L172
S163-p
PEGDAsPstPEENEt
0 5
PINX1 (human) PEGDAsPstPEENEt S163-p
PINX1 (mouse) EVNTSLTTTTTTTSA T174
PINX1 (rat) EADTSLTTTTTTTSA T174
T164-p
EGDAsPstPEENEtt
0 20
PINX1 (human) EGDAsPstPEENEtt T164-p
PINX1 (mouse) VNTSLTTTTTTTSAF T175
PINX1 (rat) ADTSLTTTTTTTSAF T175
T170-p
stPEENEttTTsAFT
0 2
PINX1 (human) stPEENEttTTsAFT T170-p
PINX1 (mouse) NTSLTTTTTTTSAFT T176
PINX1 (rat) DTSLTTTTTTTSAFT T176
T171-p
tPEENEttTTsAFTI
0 1
PINX1 (human) tPEENEttTTsAFTI T171-p
PINX1 (mouse) TSLTTTTTTTSAFTI T177
PINX1 (rat) TSLTTTTTTTSAFTI T177
S174-p
ENEttTTsAFTIQEY
0 1
PINX1 (human) ENEttTTsAFTIQEY S174-p
PINX1 (mouse) TTTTTTTSAFTIQEY S180
PINX1 (rat) TTTTTTTSAFTIQEY S180
S200-p
PQVPVPGsDISETQV
Upstream
0 1
Treatment
  • nocodazole
PINX1 (human) PQVPVPGsDISETQV S200-p
PINX1 (mouse) PQASAPGSDLSEtPV S206
PINX1 (rat) SQAAAPGSDLSETPI S206
T205
PGsDISETQVERKRG
0 1
PINX1 (human) PGsDISETQVERKRG T205
PINX1 (mouse) PGSDLSEtPVERKKG T211-p
PINX1 (rat) PGSDLSETPIEWKKG T211
K222
RNKEATGKDVEsyLQ
0 8
PINX1 (human) RNKEATGKDVEsyLQ K222
PINX1 (mouse) KNKEAADtDVENsPQ T228-p
PINX1 (rat) KTKEAAGTDIENsPQ T228
S226-p
ATGKDVEsyLQPkAK
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • GW_843682X
  • nocodazole
PINX1 (human) ATGKDVEsyLQPkAK S226-p
PINX1 (mouse) AADtDVENsPQHKAK N232
PINX1 (rat) AAGTDIENsPQHKAK N232
Y227-p
TGKDVEsyLQPkAKR
0 16
PINX1 (human) TGKDVEsyLQPkAKR Y227-p
PINX1 (mouse) ADtDVENsPQHKAKR S233-p
PINX1 (rat) AGTDIENsPQHKAKR S233-p
K231-sm
VEsyLQPkAKRHTEG
0 1
PINX1 (human) VEsyLQPkAKRHTEG K231-sm
PINX1 (mouse) VENsPQHKAKRHKKK K237
PINX1 (rat) IENsPQHKAKRHKKK K237
K252-m1
AQERVAKkKSAPAEE
0 1
PINX1 (human) AQERVAKkKSAPAEE K252-m1
PINX1 (mouse) AERGPVAKKRDRAEL K256
PINX1 (rat) AERGPAAKKRDQVEL K256
C265
EEQLRGPCWDQSSKA
0 4
PINX1 (human) EEQLRGPCWDQSSKA C265
PINX1 (mouse) ELQPGGPsEDECsDA S269-p
PINX1 (rat) ELQPGGPSGDECSDA S269
S270
GPCWDQSSKASAQDA
0 4
PINX1 (human) GPCWDQSSKASAQDA S270
PINX1 (mouse) GPsEDECsDAsVEAA S274-p
PINX1 (rat) GPSGDECSDASVEAA S274
S273
WDQSSKASAQDAGDH
0 4
PINX1 (human) WDQSSKASAQDAGDH S273
PINX1 (mouse) EDECsDAsVEAAEDC S277-p
PINX1 (rat) GDECSDASVEAAEDR S277
P283
DAGDHVQPPEGRDFt
0 1
PINX1 (human) DAGDHVQPPEGRDFt P283
PINX1 (mouse) AAEDCVQtPDIQDDV T287-p
PINX1 (rat) AAEDRVQTPDTQDDV T287
T290-p
PPEGRDFtLKPKKRR
0 2
PINX1 (human) PPEGRDFtLKPKKRR T290-p
PINX1 (mouse) tPDIQDDVPKPKKRK V294
PINX1 (rat) TPDTQDDVPKPRKRR V294
T317-p
EDATLEEtLVKKKKK
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • GW_843682X
  • nocodazole
PINX1 (human) EDATLEEtLVKKKKK T317-p
PINX1 (mouse) IDATLDRAPVKKKKK A321
PINX1 (rat) VDTAPDSAPVKKKKK A321